| Nonviral delivery of self-amplifying RNA vaccines AJ Geall, A Verma, GR Otten, CA Shaw, A Hekele, K Banerjee, Y Cu, ... Proceedings of the National Academy of Sciences 109 (36), 14604-14609, 2012 | 748 | 2012 |
| Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodes Y Li, YTH Cu, D Luo Nature biotechnology 23 (7), 885-889, 2005 | 602 | 2005 |
| Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA KA Woodrow, Y Cu, CJ Booth, JK Saucier-Sawyer, MJ Wood, ... Nature materials 8 (6), 526-533, 2009 | 495 | 2009 |
| Controlled surface modification with poly (ethylene) glycol enhances diffusion of PLGA nanoparticles in human cervical mucus Y Cu, WM Saltzman Molecular pharmaceutics 6 (1), 173-181, 2009 | 323 | 2009 |
| Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion WM Bogers, H Oostermeijer, P Mooij, G Koopman, EJ Verschoor, D Davis, ... The Journal of infectious diseases 211 (6), 947-955, 2015 | 189 | 2015 |
| Mathematical modeling of molecular diffusion through mucus Y Cu, WM Saltzman Advanced drug delivery reviews 61 (2), 101-114, 2009 | 143 | 2009 |
| In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery Y Cu, CJ Booth, WM Saltzman Journal of controlled release 156 (2), 258-264, 2011 | 141 | 2011 |
| Stealth particles give mucus the slip Y Cu, WM Saltzman Nature materials 8 (1), 11-13, 2009 | 104 | 2009 |
| Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ Y Cu, KE Broderick, K Banerjee, J Hickman, G Otten, S Barnett, G Kichaev, ... Vaccines 1 (3), 367-383, 2013 | 102 | 2013 |
| Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency Y Cu, C LeMoëllic, MJ Caplan, WM Saltzman Nanomedicine: Nanotechnology, Biology and Medicine 6 (2), 334-343, 2010 | 32 | 2010 |
| Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity P Kuo-Haller, Y Cu, J Blum, JA Appleton, WM Saltzman Molecular pharmaceutics 7 (5), 1585-1595, 2010 | 25 | 2010 |
| A dendrimer-like DNA-based vector for DNA delivery: a viral and nonviral hybrid approach D Luo, Y Li, SH Um, Y Cu DNA vaccines: Methods and Protocols, 115-125, 2006 | 16 | 2006 |
| Sustained pulmonary delivery of a water-soluble antibiotic without encapsulating carriers W Ong, P Nowak, Y Cu, L Schopf, J Bourassa, E Enlow, SM Moskowitz, ... Pharmaceutical research 33, 563-572, 2016 | 10 | 2016 |
| Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen K Banerjee, Y Cu, Y Sun, K Hartog, A Dey, L Brito, A Verma, A Nandi, ... Retrovirology 9, 1-1, 2012 | 2 | 2012 |
| Meropenem derivatives and uses thereof WZ Ong, PW Nowak, J Kim, EM Enlow, J Bourassa, Y Cu, A Popov, ... US Patent 10,392,388, 2019 | 1 | 2019 |
| Meropenem derivatives and uses thereof WZ Ong, PW Nowak, J Kim, EM Enlow, J Bourassa, Y Cu, A Popov, ... US Patent 9,725,451, 2017 | 1 | 2017 |
| Macaques primed with self-amplifying RNA vaccines expressing HIV-1 envelope and boosted with recombinant protein show potent T-and B-cell responses WM Bogers, H Oostermeijer, P Mooij, G Koopman, E Verschoor, D Davis, ... Retrovirology 9, 1-1, 2012 | 1 | 2012 |
| Engineered PLGA particles for mucosal vaccine delivery YTH Cu Yale University, 2010 | 1 | 2010 |
| Meropenem derivatives and uses thereof WZ Ong, PW Nowak, J Kim, EM Enlow, J Bourassa, Y Cu, A Popov, ... US Patent App. 17/369,806, 2021 | | 2021 |
| Meropenem derivatives and uses thereof WZ Ong, PW Nowak, J Kim, EM Enlow, J Bourassa, Y Cu, A Popov, ... US Patent 11,091,487, 2021 | | 2021 |
W. Mark SaltzmanProfessor of Biomedical Engineering, Yale UniversityEmail verificata su yale.edu